Publications by authors named "K G Samsom"

Article Synopsis
  • Oncology is shifting towards genome-driven practices, but most cancer diagnostics still rely on traditional microscopy methods, creating delays in using new genomic biomarkers for patient treatment.* -
  • Whole-genome sequencing (WGS) can improve diagnostics by detecting numerous genomic changes in one cost-effective test, and it has been shown to be feasible and valid in a clinical setting, with results provided in about 11 workdays.* -
  • Successful WGS implementation, such as at the Netherlands Cancer Institute, requires a detailed protocol addressing sample handling and integration into clinical workflows to overcome challenges faced by pathology labs using conventional sample methods.*
View Article and Find Full Text PDF

Neuroendocrine neoplasms (NENs) comprise well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Treatment options for patients with NENs are limited, in part due to lack of accurate models. We establish patient-derived tumor organoids (PDTOs) from pulmonary NETs and derive PDTOs from an understudied subtype of NEC, large cell neuroendocrine carcinoma (LCNEC), arising from multiple body sites.

View Article and Find Full Text PDF

Purpose: Genome sequencing (GS) enables comprehensive molecular analysis of tumors and identification of hereditary cancer predisposition. According to guidelines, directly determining pathogenic germline variants (PGVs) requires pretest genetic counseling, which is cost-ineffective. Referral for genetic counseling based on tumor variants alone could miss relevant PGVs and/or result in unnecessary referrals.

View Article and Find Full Text PDF

Background: In ∼3%-5% of patients with metastatic disease, tumor origin remains unknown despite modern imaging techniques and extensive pathology work-up. With long diagnostic delays and limited and ineffective therapy options, the clinical outcome of patients with cancer of unknown primary (CUP) remains poor. Large-scale genome sequencing studies have revealed that tumor types can be predicted based on distinct patterns of somatic variants and other genomic characteristics.

View Article and Find Full Text PDF

The current increase in number and diversity of targeted anticancer agents poses challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in underdiagnosis and treatment. Whole-genome sequencing (WGS) may provide a sustainable solution for addressing current as well as future diagnostic challenges. The present study therefore aimed to prospectively assess feasibility, validity, and value of WGS in routine clinical practice.

View Article and Find Full Text PDF